StockCIK 1736730

Camp4 Therapeutics Corp (CAMP): Insider Trades and Fund Holdings

In the past 12 months, Camp4 Therapeutics Corp insiders reported 1 open-market purchase worth $40K and 6 sales worth $2.50M; 0 of the sales were reported as made under a 10b5-1 trading plan.

1Insider buys, 12 months

$40KBought by insiders, 12 months

$2.50MSold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 2, 2026.

Recent CAMP insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 2	Aug 31	Kelly GoldCFO	CFO (ind.)	▲ BUY	10,000	3.96	$40K	New	Form 4 ↗
Aug 31	Aug 27	Andrew J. SchwabDirector	Director (ind.)	▼ SELL	400,000	4.04	$1.62M	−16%	Form 4 ↗
Aug 26	Aug 24	Andrew J. SchwabDirector	Director (ind.)	▼ SELL	10	4.50	$45	+0.0%	Form 4 ↗
Aug 21	Aug 20	Andrew J. SchwabDirector	Director (ind.)	▼ SELL	114,700	4.54	$521K	−4.4%	Form 4 ↗
Aug 21	Aug 19	Andrew J. SchwabDirector	Director (ind.)	▼ SELL	45,147	4.76	$215K	−1.7%	Form 4 ↗
Aug 21	Aug 21	Andrew J. SchwabDirector	Director (ind.)	▼ SELL	32,018	4.50	$144K	−1.3%	Form 4 ↗
Aug 19	Aug 19	Daniel TardiffChief Scientific Officer	Chief Scientific Officer	▼ SELL	1,738	4.76	$8K	All sold	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Kelly Gold	CFO	1	$40K	0	$0	Sep 2, 2026
Andrew J. Schwab	Director	0	$0	5	$2.50M	Aug 31, 2026
Daniel Tardiff	Chief Scientific Officer	0	$0	1	$8K	Aug 19, 2026

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →